Streptomycin Sulphate Prices

Streptomycin Sulphate Prices June 2023

In the second quarter of 2023, the price of streptomycin sulphate in the United States reached 35690 USD/MT by June. Similarly, in China, the streptomycin sulphate prices hit 33137 USD/MT in the same month. Germany also saw streptomycin sulphate prices reaching 37110 USD/MT during Q2 2023.

Streptomycin Sulphate Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Streptomycin Sulphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of streptomycin sulphate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of streptomycin sulphate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of streptomycin sulphate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing streptomycin sulphate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Streptomycin Sulphate Market Analysis

The global streptomycin sulphate market size reached US$ 122.7 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 177.6 Million, at a projected CAGR of 4.20% during 2023-2032.

• The rising incidence of tuberculosis (TB) is driving the demand for effective treatments such as streptomycin sulphate. It is an essential component in the treatment of multidrug-resistant TB (MDR-TB). According to the World Health Organization (WHO), a total of 1.3 million people died from TB in 2022 (including 167000 people with HIV). Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS). In 2022, an estimated 10.6 million people fell ill with TB worldwide, including 5.8 million men, 3.5 million women, and 1.3 million children. Only about 2 in 5 people with drug-resistant TB accessed treatment in 2022. US$ 13 billion is needed annually for TB prevention, diagnosis, treatment, and care to achieve the global target agreed at the 2018 UN high-level meeting on TB. Ending the TB epidemic by 2030 is among the health targets of the United Nations Sustainable Development Goals (SDGs).
• The growing programs and initiatives by governments and non-governmental organizations to combat TB and other infectious diseases are boosting the market. These initiatives often include the provision of antibiotics such as streptomycin sulfate. According to the Ministry of Health and Family Welfare, the Government of India (GoI), the incidence of TB has reduced by 18% from 256/lakh population in 2015 to 210/lakh population in 2021. At the same time, the estimates of Drug Resistant TB in India have reduced by 20% from 1.49 lakh in 2015 to 1.19 lakh in 2021. The Government of India has developed a National Strategic Plan (2017-25) for Ending TB in the country by 2025.  Universal Drug Susceptibility Testing (UDST) is implemented under the NTEP to ensure every diagnosed TB patient is tested to rule out drug resistance before or at the time of treatment initiation itself.
• Improved healthcare infrastructure and increased awareness about bacterial infections and their treatments led to higher diagnosis rates and subsequent demand for antibiotics, such as streptomycin sulphate, thereby supporting the market growth.

Streptomycin Sulphate News

The report covers the latest developments, updates, and trends impacting the global streptomycin sulphate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in streptomycin sulphate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the streptomycin sulphate price trend.

Product Description

Streptomycin sulphate refers to an antibiotic derived from Streptomyces griseus, a soil bacterium. It belongs to the aminoglycoside class of antibiotics and is majorly employed to treat bacterial infections. It works by inhibiting protein synthesis in bacteria, thus preventing their growth and proliferation. Streptomycin sulphate is especially effective against Mycobacterium tuberculosis, making it a key component in the treatment of tuberculosis. Besides TB, it is also used to treat other infections caused by gram-negative bacteria such as plague and tularemia. Administered via intramuscular injection, it can lead to side effects such as nephrotoxicity (kidney damage) and ototoxicity (hearing loss), requiring careful monitoring during treatment. Due to these potential adverse effects, its use is typically reserved for situations where other antibodies are contraindicated or ineffective.

Regional Coverage

The report provides a detailed analysis of the streptomycin sulphate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the streptomycin sulphate price trend. 

Global Streptomycin Sulphate Price

The report offers a holistic view of the global streptomycin sulphate pricing trends in the form of streptomycin sulphate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of streptomycin sulphate but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed streptomycin sulphate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Streptomycin Sulphate Price

European streptomycin sulphate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed streptomycin sulphate price information for a comprehensive list of countries.

North America Streptomycin Sulphate Price

The analysis of streptomycin sulphate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific streptomycin sulphate historical data within the United States and Canada can also be provided.

Middle East and Africa Streptomycin Sulphate Price

The report explores the streptomycin sulphate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on streptomycin sulphate prices for countries can also be provided.

Asia Pacific Streptomycin Sulphate Price

The streptomycin sulphate pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This streptomycin sulphate price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Streptomycin Sulphate Price

The analysis of streptomycin sulphate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of streptomycin sulphate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting streptomycin sulphate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The streptomycin sulphate price charts ensure our clients remain at the forefront of the industry.